Editorial
Psychosis Risk With Prescription Amphetamine
American Journal of Psychiatry · 2024
DOI: 10.1176/appi.ajp.20240732 ↗Kurz gefasst
Editorial in der Zeitschrift American Journal of Psychiatry, 2024. Verfasst von Carol A Tamminga. Beteiligte Einrichtung: Department of Psychiatry, UT Southwestern Medical Center, Dallas. Hauptthemen laut MEDLINE: Amphetamine, Amphetamine-Related Disorders, Psychoses, Substance-Induced, Prescription Drugs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AmphetamineAmphetamine-Related DisordersPsychoses, Substance-InducedPrescription DrugsHumansCentral Nervous System StimulantsPsychotic DisordersRisk Factors
Stichwörter der Autor:innen
AmphetaminesPsychopharmacologyPsychosisSchizophrenia Spectrum and Other Psychotic Disorders
Substanzen
AmphetamineCentral Nervous System StimulantsPrescription Drugs
Autor:innen und Institutionen
- Department of Psychiatry, UT Southwestern Medical Center, Dallas.
Zitieren
APA
Tamminga, C. A. (2024). Psychosis Risk With Prescription Amphetamine. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.20240732
Vancouver
Tamminga CA. Psychosis Risk With Prescription Amphetamine. American Journal of Psychiatry. 2024. doi:10.1176/appi.ajp.20240732
BibTeX
@article{Tamminga2024,
author = {Tamminga, Carol A},
title = {Psychosis Risk With Prescription Amphetamine},
journal = {American Journal of Psychiatry},
year = {2024},
doi = {10.1176/appi.ajp.20240732}
}
EUVIMED